These data showed a large overlap in the antibodies generated in response to tularemia infection or LVS vaccination.
A total of seven proteins were observed to be reactive with 60% or more sera from vaccinees and convalescents.
A further four proteins were recognised by 30–60% of the sera screened.
These proteins have the potential to serve as markers of vaccination or candidates for subunit vaccines.